Ventura County Star features Oxnard-based CURE Pharmaceutical

Interest in cannabis-based medicine is on the rise, and Oxnard-based CURE Pharmaceutical is positioning itself to become a key player in the burgeoning industry.

CURE Pharmaceutical, founded in 2011, might be small, but the company is carving a niche for itself in a county that has no shortage of biopharmaceutical businesses.

Read the full article: Oxnard’s CURE Pharmaceutical looks to grow its business through cannabis-based medicine (Ventura County Star)

August 9th, 2018|Categories: Client News|Tags: , , , |

CUREfilm redefines how medicines are delivered and experienced

The CUREfilm technology, developed by Cure Pharmaceutical, delivers drugs through a dissolvable strip that can be applied in the oral cavity or onto the skin. It replaces the need for swallowing or injecting medicines. The film has the ability to hold multiple active ingredients on one dissolvable strip, hence, eliminating the need to take multiple medications for daily treatments.

“CUREfilm products are designed to optimize drug release profiles and achieve a target product profile,” says Jessica Rousset, COO at CURE Pharmaceutical. “Unlike traditional oral drug delivery, CUREfilm can be designed to bypass the gastrointestinal (GI) tract, avoiding GI-related side effects and inactivation in the gut or liver.”

Rousset spoke to Pharmaceutical Technology about the advantages of CUREfilm and its applications in drug delivery.

Read the full article: An alternative to pills and injections: CUREfilm redefines how medicines are delivered and experienced (Pharmaceutical Technology)

June 8th, 2018|Categories: Client News|Tags: , , , , , |

CURE Pharmaceutical’s Steven Ruhl on raw materials and functional excipients

Steven Ruhl, VP of manufacturing for CURE Pharmaceutical, was featured in a roundtable in the April edition of the American Pharmaceutical Review on “Raw Materials and Functional Excipients.”

“Regulatory and quality expectations of excipients will continue to increase,” said Ruhl, “which has put more pressure on excipient and raw material companies to invest in characterizing functionality and building robust processes to consistently address company needs. This has led to a greater focus on understanding critical material attributes and ranges by both suppliers and customers earlier in the development process.”

Read the full article: Raw Materials and Functional Excipients (American Pharmaceutical Review)

OWC adds two healthcare leaders to client portfolio

OWC has been retained by two healthcare clients to its growing roster. CURE Pharmaceutical (OTC: CURR) is an innovative drug delivery company, and Saban Community Clinic is a federally-qualified health center providing low-cost, integrated health care to the Los Angeles community.

“Healthcare is one of the fastest growing markets in the country, and we are fortunate to work with two innovators,” said Tracy Williams, OWC founder and CEO. “CURE Pharmaceutical and Saban Community Clinic are two organizations that are changing patient’s lives and improving the delivery healthcare to those in need.”

Read the full announcement: Olmstead Williams Communications Adds Two Healthcare Leaders to Client Portfolio (iReach)